Alzheimer’s disease is a neurodegenerative condition that can cause difficulties with thinking and memory and physical decline. Biomarkers can help experts monitor its development, progression, and ...

Recent research is helping to expand the potential biomarker landscape in non–small cell lung cancer (NSCLC) and may soon ...

Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.

We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 19 Table 1 summarizes the eligibility criteria. Study design Quantitative (interventional or ...

ATPase inhibitory factor 1 (IF1) has been hypothesized as a biomarker of mitochondrial energy metabolism in which higher levels are associated with protection against insulin resistance. Among people ...

Researchers at the University of Geneva have built a molecular system that can tell the difference between a cancer cell and ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

Rising demand for personalized oncology therapies, AI-driven biomarker discovery, expanding precision diagnostics, and liquid ...

"This study aimed to identify bioimaging biomarkers that could possibly correlate with amyloid patients. If a careful medical history is taken from the patient, the right multimodal imaging is ...

The "Cancer Biomarkers Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Biomarker, Type of Cancer and Key Geographical Regions" report has been added to ...